SMTL ID : 2r9n.2 (1 other biounit)

Cathepsin S complexed with Compound 26

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x Y14: N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin-3-yl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide(Non-covalent)

Y14.1: 19 residues within 4Å: Chain A: Q.19, G.23, A.24, C.25, W.26, G.62, K.64, N.67, G.68, G.69, F.70, M.71, A.140, R.141, F.146, V.162, N.163, H.164, W.186 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.140, A:R.141, A:F.146, A:V.162, A:H.164, A:W.186 Hydrogen bonds: A:Q.19, A:C.25, A:G.69, A:G.69, A:N.163 pi-Stacking: A:H.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, Y.D. et al., Design and Synthesis of Reversible Inhibitors of Cathepsin S: alpha,alpha-Disubstitution at the P1 Residue Provides Potent Inhibitors in Cellular Assays and In Vivo Models of Antigen Presentation. to be published

Release Date

2007-12-18

Peptides

Cathepsin S: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Cathepsin S

Related Entries With Identical Sequence